Literature DB >> 28830030

Multivariate trajectories across multiple domains of health-related quality of life in children with new-onset epilepsy.

Tolulope T Sajobi1, Meng Wang2, Mark A Ferro3, Anita Brobbey4, Shane Goodwin5, Kathy N Speechley6, Samuel Wiebe7.   

Abstract

The diagnosis of epilepsy in children is known to impact the trajectory of their health-related quality of life (HRQOL) over time. However, there is limited knowledge about variations in longitudinal trajectories across multiple domains of HRQOL. This study aims to characterize the heterogeneity in HRQOL trajectories across multiple HRQOL domains and to evaluate predictors of differences among the identified trajectory groups in children with new-onset epilepsy. Data were obtained from the Health Related Quality of Life in Children with Epilepsy Study (HERQULES), a prospective multi-center study of 373 children newly diagnosed with new-onset epilepsy who were followed up over 2years. Child HRQOL and family factors were reported by parents, and clinical characteristics were reported by neurologists. Group-based multi-trajectory modeling was adopted to characterize longitudinal trajectories of HRQOL as measured by the individual domains of cognitive, emotional, physical, and social functioning in the 55-item Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55). Multinomial logistic regression was used to assess potential factors that explain differences among the identified latent trajectory groups. Three distinct HRQOL trajectory subgroups were identified in children with new-onset epilepsy based on HRQOL scores: "High" (44.7%), "Intermediate" (37.0%), and "Low" (18.3%). While most trajectory groups exhibited increasing scores over time on physical and social domains, both flat and declining trajectories were noted on emotional and cognitive domains. Less severe epilepsy, an absence of cognitive and behavioral problems, lower parental depression scores, better family functioning, and fewer family demands were associated with a "Higher" or "Intermediate" HRQOL trajectory. The course of HRQOL over time in children with new-onset epilepsy appears to follow one of three different trajectories. Addressing the clinical and psychosocial determinants identified for each pattern can help clinicians provide more targeted care to these children and their families.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Group-based trajectory analysis; Health-related quality of life; New-onset epilepsy; Pediatric population; Prospective study

Mesh:

Year:  2017        PMID: 28830030     DOI: 10.1016/j.yebeh.2017.07.037

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

Review 1.  Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy.

Authors:  Bruce P Hermann; Aaron F Struck; Robyn M Busch; Anny Reyes; Erik Kaestner; Carrie R McDonald
Journal:  Nat Rev Neurol       Date:  2021-09-22       Impact factor: 44.711

2.  Psychometric Properties of the Turkish Version of the Epilepsy Module of the KINDL Quality of Life Scale.

Authors:  Dilek Ergin; Selin Demirbağ; Erhan Eser; Muzaffer Polat; Hakan Baydur
Journal:  Noro Psikiyatr Ars       Date:  2021-11-02       Impact factor: 1.066

3.  Behavioral phenotypes of childhood idiopathic epilepsies.

Authors:  Bruce P Hermann; Aaron F Struck; Carl E Stafstrom; David A Hsu; Kevin Dabbs; Carson Gundlach; Dace Almane; Michael Seidenberg; Jana E Jones
Journal:  Epilepsia       Date:  2020-06-18       Impact factor: 5.864

4.  Behavioral phenotypes of temporal lobe epilepsy.

Authors:  Bruce P Hermann; Aaron F Struck; Kevin Dabbs; Mike Seidenberg; Jana E Jones
Journal:  Epilepsia Open       Date:  2021-05-05

5.  Longitudinal mediation analysis of the factors associated with trajectories of posttraumatic stress disorder symptoms among postpartum women in Northwest Ethiopia: Application of the Karlson-Holm-Breen (KHB) method.

Authors:  Marelign Tilahun Malaju; Getu Degu Alene; Telake Azale Bisetegn
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.